Discover open access scientific publications

Search, annotate, share and cite publications

Publications by DD Ruff

Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients With Migraine: Results From Two Global Phase 3 Clinical Trials

Value in Health

English

Related publications

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Headache

Neurology

2019

English

Costs of Acute Headache Medication Use and Productivity Losses Among Patients With Migraine: Insights From Three Randomized Controlled Trials

PharmacoEconomics - Open

Health Policy

Pharmacology

2018

English

Healthcare Resource Utilization in a Phase 3 Study of CPX-351 in Patients With Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukemia

Journal of Medical Economics

Health Policy

2020

English

Efficacy and Safety of Lasmiditan in Patients Using Concomitant Migraine Preventive Medications: Findings From SAMURAI and SPARTAN, Two Randomized Phase 3 Trials

Journal of Headache and Pain

English

Different Doses of Galcanezumab Versus Placebo in Patients With Migraine and Cluster Headache: A Meta-Analysis of Randomized Controlled Trials

Journal of Headache and Pain

English

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

Journal of Cancer

Oncology

2012

English

Medication Use in Patients With Migraine and Medication-Overuse Headache: The Role of Problem-Solving and Attitudes About Pain Medication

English

Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials

Clinics in Geriatric Medicine

Gerontology

Geriatrics

2011

English

Clinical Burden and Healthcare Resource Utilization Associated With Myasthenia Gravis: Assessments From a Japanese Claims Database

Clinical and Experimental Neuroimmunology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by DD Ruff

Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients With Migraine: Results From Two Global Phase 3 Clinical Trials

Related publications

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Costs of Acute Headache Medication Use and Productivity Losses Among Patients With Migraine: Insights From Three Randomized Controlled Trials

Healthcare Resource Utilization in a Phase 3 Study of CPX-351 in Patients With Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukemia

Efficacy and Safety of Lasmiditan in Patients Using Concomitant Migraine Preventive Medications: Findings From SAMURAI and SPARTAN, Two Randomized Phase 3 Trials

Different Doses of Galcanezumab Versus Placebo in Patients With Migraine and Cluster Headache: A Meta-Analysis of Randomized Controlled Trials

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

Medication Use in Patients With Migraine and Medication-Overuse Headache: The Role of Problem-Solving and Attitudes About Pain Medication

Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials

Clinical Burden and Healthcare Resource Utilization Associated With Myasthenia Gravis: Assessments From a Japanese Claims Database